Mobix Labs is trading 5.5% down at $1.20 after disclosing a delayed Form 10-Q, citing complex financing transactions and accounting-department turnover.
- The delay follows August 13 preliminary results and guidance, including fiscal third-quarter revenue of $750,000β$850,000 and fourth-quarter revenue of $1.4 millionβ$1.8 million.
- Strategic pivot and proposed all-stock acquisition of Special Project Delivery add execution and dilution uncertainty, with consideration of up to 4.8 million shares.
- The broader market is modestly mixed, so company-specific concerns appear more relevant.